- Home
- DPRO vs FBRX Comparison
DPRO vs FBRX Comparison
Compare DPRO & FBRX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- DPRO
- FBRX
- Stock Information
- Founded
- DPRO 1998
- FBRX N/A
- Country
- DPRO Canada
- FBRX United States
- Employees
- DPRO N/A
- FBRX N/A
- Industry
- DPRO Aerospace
- FBRX Biotechnology: Pharmaceutical Preparations
- Sector
- DPRO Industrials
- FBRX Health Care
- Exchange
- DPRO Nasdaq
- FBRX Nasdaq
- Market Cap
- DPRO 175.1M
- FBRX 154.5M
- IPO Year
- DPRO N/A
- FBRX N/A
- Fundamental
- Price
- DPRO $8.95
- FBRX $14.38
- Analyst Decision
- DPRO Strong Buy
- FBRX Strong Buy
- Analyst Count
- DPRO 1
- FBRX 3
- Target Price
- DPRO $14.00
- FBRX $68.00
- AVG Volume (30 Days)
- DPRO 5.9M
- FBRX 97.8K
- Earning Date
- DPRO 11-13-2025
- FBRX 11-13-2025
- Dividend Yield
- DPRO N/A
- FBRX N/A
- EPS Growth
- DPRO N/A
- FBRX N/A
- EPS
- DPRO N/A
- FBRX N/A
- Revenue
- DPRO $5,250,872.00
- FBRX N/A
- Revenue This Year
- DPRO $41.59
- FBRX N/A
- Revenue Next Year
- DPRO $137.37
- FBRX N/A
- P/E Ratio
- DPRO N/A
- FBRX N/A
- Revenue Growth
- DPRO 17.08
- FBRX N/A
- 52 Week Low
- DPRO $1.63
- FBRX $4.11
- 52 Week High
- DPRO $14.40
- FBRX $28.68
- Technical
- Relative Strength Index (RSI)
- DPRO 51.51
- FBRX 58.56
- Support Level
- DPRO $8.31
- FBRX $11.00
- Resistance Level
- DPRO $10.19
- FBRX $15.01
- Average True Range (ATR)
- DPRO 1.20
- FBRX 1.04
- MACD
- DPRO -0.35
- FBRX 0.10
- Stochastic Oscillator
- DPRO 25.68
- FBRX 75.28
About DPRO Draganfly Inc.
Draganfly Inc is a Canada based company. It is engaged in the provision of engineering services and the manufacture of commercial unmanned vehicle systems and software. The company operates in Canada, the United States, and Internationally. The three segments are Drones, Vital (Vital Intelligence), and Corporate. The Drones segment derives its revenue from products and services related to the sale of unmanned aerial vehicles (UAV). The Vital segment derives its revenue from the sale of products that measure vitals to help detect symptoms from large groups of people from a distance. The Corporate segment includes all costs not directly associated with the Drone and Vital segments. It generates majority of its revenue from Drones segment.
About FBRX Forte Biosciences Inc.
Forte Biosciences Inc is a biopharmaceutical company that is advancing through preclinical trials its product candidate, FB-102, which is a proprietary therapeutic molecule with potentially broad autoimmune applications in such indications as graft-versus-host disease (GvHD), vitiligo, alopecia areata, and type 1 diabetes (T1D).